Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/22/17 16:17 | 4/25/17 | STDY | Health | Drug | Pharmaceutical Preparations | Stark Brian Jay | CA | DT | P.d | 2,968 | 5.90 | 0 | 503 | 12 | 4,697 | M | |||||||||||||||
4/27/17 16:58 | 4/25/17 | STDY | Health | Drug | Pharmaceutical Preparations | Orbimed Advisors LLC | NY | T | P.d | 6,927 | 5.90 | 3 | 1,174 | 124 | 2,123 | I | -35 | 40 | 62 | 140 | 51 | -8 | 2 | 1 | 13 | 14 | |||||
8/8/16 16:57 | 8/4/16 | STDY | Health | Drug | Pharmaceutical Preparations | Stark Brian Jay | CA | DT | P.d | 4,103 | 3.13 | 0 | 1,311 | 45 | 4,194 | M | -42 | 21 | -16 | 9 | -7 | -7 | 1 | -1 | 0 | 11 | 13 | -5 | |||
8/8/16 16:55 | 8/4/16 | STDY | Health | Drug | Pharmaceutical Preparations | Steadymed Investors, LLC | CA | T | P.d | 833 | 3.13 | 0 | 266 | 12 | 2,536 | I | -42 | 21 | -16 | 9 | -7 | -7 | 1 | -1 | 0 | 11 | 13 | -5 | |||
8/8/16 16:53 | 8/4/16 | STDY | Health | Drug | Pharmaceutical Preparations | Bank Keith | CA | DT | P.d | 833 | 3.13 | 0 | 266 | 11 | 2,590 | I | -42 | 21 | -16 | 9 | -7 | -7 | 1 | -1 | 0 | 11 | 13 | -5 | |||
3/25/15 17:19 | 3/25/15 | STDY | Health | Drug | Pharmaceutical Preparations | Flynn James E | NY | TH | Possible | P.d | 6,269 | 8.50 | 1 | 738 | 139 | 1,268 | I | 1 | 1 | 20 | -32 | -58 | -68 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |